AR131006A1 - Compuestos novedosos - Google Patents

Compuestos novedosos

Info

Publication number
AR131006A1
AR131006A1 ARP230103005A ARP230103005A AR131006A1 AR 131006 A1 AR131006 A1 AR 131006A1 AR P230103005 A ARP230103005 A AR P230103005A AR P230103005 A ARP230103005 A AR P230103005A AR 131006 A1 AR131006 A1 AR 131006A1
Authority
AR
Argentina
Prior art keywords
novel compounds
compounds
novel
methods
general formula
Prior art date
Application number
ARP230103005A
Other languages
English (en)
Inventor
Thomas Alexander Alanine
Lea Aurelie Bouche
Wolfgang Guba
Georg Jaeschke
Stefanie Katharina Mesch
Jonathan Martin Shannon
Andreas Michael Tosstorff
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR131006A1 publication Critical patent/AR131006A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², R³, R⁴ᵃ, R⁴ᵇ y R⁵ son como se describe en la presente, composición que incluye los compuestos y métodos para usar los compuestos.
ARP230103005A 2022-11-09 2023-11-08 Compuestos novedosos AR131006A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22206280 2022-11-09

Publications (1)

Publication Number Publication Date
AR131006A1 true AR131006A1 (es) 2025-02-05

Family

ID=84330428

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230103005A AR131006A1 (es) 2022-11-09 2023-11-08 Compuestos novedosos

Country Status (7)

Country Link
US (1) US20260193228A1 (es)
EP (1) EP4615830A1 (es)
JP (1) JP2025537238A (es)
CN (1) CN120152964A (es)
AR (1) AR131006A1 (es)
TW (1) TW202428282A (es)
WO (1) WO2024099993A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
CN121586712A (zh) * 2023-07-28 2026-02-27 豪夫迈·罗氏有限公司 新颖化合物
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法
WO2025261430A1 (zh) * 2024-06-21 2025-12-26 成都赜灵生物医药科技有限公司 苯并噻吩类氘代化合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR119731A1 (es) * 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
WO2021219784A1 (en) * 2020-04-30 2021-11-04 Janssen Pharmaceutica Nv New triazinoindole compounds

Also Published As

Publication number Publication date
TW202428282A (zh) 2024-07-16
US20260193228A1 (en) 2026-07-09
WO2024099993A1 (en) 2024-05-16
CN120152964A (zh) 2025-06-13
EP4615830A1 (en) 2025-09-17
JP2025537238A (ja) 2025-11-14

Similar Documents

Publication Publication Date Title
AR130984A1 (es) Compuestos novedosos
AR123424A1 (es) Nuevos compuestos heterocíclicos
AR131282A1 (es) Compuestos novedosos
AR131278A1 (es) Compuestos novedosos
CL2021001330A1 (es) Nuevos compuestos heterocíclicos
CL2024004085A1 (es) Compuestos macrocíclicos inhibidores de kras, uso para tratar cáncer.
AR132377A1 (es) Compuestos novedosos
CO2023014721A2 (es) Compuestos heterocíclicos
CL2022001091A1 (es) Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871).
CL2023003312A1 (es) Inhibidores de nlrp3
CL2022000019A1 (es) Nuevos compuestos heterocíclicos
AR132456A1 (es) Compuestos novedosos
CL2024001565A1 (es) Compuestos macrocíclicos con actividad inhibidora de la farnesiltransferasa, composición que los comprende y su uso.
AR133266A1 (es) Macrociclos para el tratamiento de enfermedades autoinmunitarias
MX2023015490A (es) Inhibidores de las transglutaminasas.
CR20240203A (es) Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2
AR132992A1 (es) Agonistas de trem2
CL2025000484A1 (es) Compuestos deuterados de pirimidin-2-il sulfonamida, uso para tratar trastornos desmielinizantes.
CL2025000126A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
CL2025000125A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
CO2022012773A2 (es) Moduladores de nampt
AR133375A1 (es) Compuestos novedosos
AR133076A1 (es) Compuestos novedosos
AR133167A1 (es) Macrociclos para el tratamiento de enfermedad autoinmunitaria
AR131633A1 (es) Derivados novedosos de pirimidinil sulfonamida